期刊文献+

PET与CT对淋巴瘤化疗疗效评价的比较

Compare ^(18)F-FDG PET Imaging with CT Imaging in the Evaluation of Chemotherapy of Lymphoma
下载PDF
导出
摘要 目的探讨18氟-氟代脱氧葡萄糖(18F-FDG)正电子发射计算机断层显像(PET)与计算机断层显像(CT)对淋巴瘤化疗疗效评价的异同。方法32例淋巴瘤患者化疗前后分别行PET/CT检查,首先分析CT图像,对淋巴瘤化疗的疗效作出评价,然后分析PET图像,再次评价淋巴瘤化疗疗效,比较2次疗效评价的差别。每位患者随访12~21个月。结果PET与CT评价淋巴瘤化疗疗效的符合率分别为96.9%、75.0%,二者比较差异有统计学意义(P=0.026)。结论PET对淋巴瘤化疗疗效的评价优于CT,然而,PET的评价存在假阳性,仍需要结合临床作出判断。 Objective To compare fluorine 18 fluorodeoxyglucose (^18F-FDG) positron emission tomography (PET) imaging with computed tomography (CT) imaging in the evaluation of chemotherapy of lymphoma. Methods 32 patients were Collected who engaged ISF-FDG PET/CT both before chemotherapy and after chemotherapy. Response was evaluated respectively with CT and PET. All patients were followed up for 12 - 21 months. Results The coincidence of PET and CT was 96.9% ,75.0% respectively. There was significant difference between PET and CT in the evaluation of chemotherapy of lymphoma( P = 0. 026 ). Conclusions The use of FDG PET may be superior assessment of response to chemotherapy than the use of CT, but it may cause false positive, the result should combine with the clinic.
出处 《医学综述》 2010年第6期952-954,共3页 Medical Recapitulate
关键词 淋巴瘤 化疗 计算机断层扫描 正电子发射计算机断层扫描 Lymphoma Chemotherapy Cmputed tomography Positron emission tomography
  • 相关文献

参考文献8

  • 1Gambhir SS,Czemin J,Schwimmer J,et al. A tabulated summary of the FDG PET literature [ J ]. J Nuel Med, 2001,42 ( 5 Suppl ) : 1 S-93 S.
  • 2Juweid ME, Wiseman GA, Vose JM, et al. Response assessment of aggressive non-Hodgkin' s lymphoma by Integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emis- sion tomography[ J]. J Clin Oncol,2005,23 (21) :4652-4661.
  • 3Rigacci L, Castagnoli A, Dini C, et al. ^18F-FDG-positron emission tomography in post treatment evaluation of residual mass in Hodgkin's lymphoma:Long - term results[ J]. Oncol Rep,2005,14 (5) :1209-1214.
  • 4田嘉禾.PET在淋巴瘤诊断方面的应用[J].实用肿瘤杂志,2005,20(2):102-105. 被引量:7
  • 5Castellucci P, Nanni C, Farsad M, et al. Potential pitfalls of ^18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation[ J]. Nucl Med Common ,2005,26 (8) :689-694.
  • 6Spaepen K, Stroobants S, Dupont P, et al. ^18F-FDG PET monitoring of tumor response to chemotherapy:Does 18F-FDG uptake correlate with the viable tumor cell fraction [ J]. Eur J Nucl Med Mol Imaging,2003,30 (5) :682-688.
  • 7Matthies A, Hickeson M, Cuchiara A. Dual time point ^18F -FDG PET for the evaluation of pulmonary nodules [ J ]. J Nucl Med ,2002, 43(7) :871-875.
  • 8杨明,李毅红,丛粮,顾倩.^(18)F-FDGPET-CT在淋巴瘤分期及疗效评价中的应用研究[J].武警医学,2008,19(8):684-687. 被引量:5

二级参考文献13

  • 1Hernandez- Maraver D, Hernandez- Navarro F, Gomez- Leon Net al . Positron emission tomography/computed tomography: diagnostic accuracy in lymphoma. Br J Haematol, 2006,135(3) :293
  • 2Rodriguez M. Computed tomography, magnetic resonance imag-ing and positron emission tomography in non2Hodgkin's lymphoma.Acta Radiol, 1996,417(Suppl): 1 236
  • 3Moog F, Bangerter M, Diederichs CG et al . Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology, 1998,206:475
  • 4Schoder H,Meta J,Yap C et al.Effect of whole 2body ^18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma.J Nucl Med,2001,42:1 139
  • 5Schaefer NG, Hany TF, Taverna C et al . Non - Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging- do we need contrast- enhanced CT?Radiology,2004,232(3) :823
  • 6Jerusalem G, Beguin Y, Fassotte MF et al . Persistent tumor ^18F- FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non - Hodgkin's lymphoma. Haematologica, 2000,85 (6) : 613
  • 7Calleuos GP. Residualmass in lymphoma may not be residual disease. J Clin Oneol, 1988,6(6) :931
  • 8DeWit M, Bumann D, BeyerW et al . Whole - body positron emission tomography (PET) for diagnosis of residualmass in patient with lymphoma. Ann Oncol, 1997,8 (suppl 1) : 57
  • 9Cremerius U, Fabry U, Neuerbmg Jet al . Positron emission tomography widl ^18F- FDG to detect residual disease after dlerapyfor malignant lymphoma. Nucl Med Commun, 1998, 19(11):1 055
  • 10Matthies A,Hickeson M, Cuchiara A. Dual time point ^18F- FDG PET for the evaluation of pulmonary nodules. J Nucl Med,2002,43(7) :871

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部